Supplements & CompoundsControlled trial · 410 people
A popular longevity supplement didn’t slow Parkinson’s in a large trial
In a year-long study of 410 people with early Parkinson’s, the supplement nicotinamide riboside (NR) raised a molecule cells use for energy, but did not slow the disease. Symptoms got slightly worse than on a dummy pill.